DGAP-Adhoc: euromicron AG: Decline in sales at euromicron

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Aug 3, 2016 at 6:00 PM

DGAP-Adhoc: euromicron AG: Decline in sales at euromicron Deutschland GmbH requires an adjustment in the forecast for sales and operating EBITDA for fiscal year 2016

euromicron Aktiengesellschaft communication & control technology / Key word(s): Change in Forecast 03.08.2016 22:35 Disclosure of an inside information according to Article 17 MAR, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- euromicron AG is adjusting its previous forecast on sales and its operating EBITDA margin for the current fiscal year 2016. According to the preliminary results for the first six months, sales amounted to EUR 139.8 million, approximately EUR 17 million lower than last year. Operating EBITDA was EUR -1.7 million and thus around EUR 5.6 million below the comparative figures from the previous year. Despite the expected strong second half of the year, the shortfall of earnings are expected to be reduced, but not completely compensated by the end of the year. Nevertheless, the numbers are significantly influenced by the fact that euromicron Deutschland GmbH finds itself in an extensive reorganisation. The high heterogeneity within the subsidiary due to the merger of several small companies delays the structural measures more than initially expected. The realignment of euromicron Deutschland GmbH therefore temporarily affects the Group's sales volume and its profitability. Consequently, the Executive Board has adjusted its forecast for the current fiscal year 2016. The adjusted volume of sales lies within a range of between EUR 330 million and EUR 350 million. The operating EBITDA margin is expected now to range between 2% and 4%. The reorganization measures initiated in the last fiscal year will be partly completed in the current financial year. The resulting costs expected for fiscal year 2016 are now being adjusted to around EUR 3 million to EUR 4 million. The company will publish the complete report on the second quarter of 2016 on August 9, 2016. --------------------------------------------------------------------------- Information and Explanation of the Issuer to this News: About euromicron euromicron AG (www.euromicron.de), a company that unites medium-sized high- tech companies from the fields of Digital Buildings, Critical Infrastructures and Smart Industry. As a German specialist for the Internet of Things, euromicron enables its customers to network business and production processes and successfully move to a digital future. From design and implementation, operation, to related services - euromicron implements customized solutions and creates the IT, network and security infrastructures that they require. As a result, euromicron enables its customers to gradually migrate existing infrastructures to the digital age. euromicron's expertise helps the company's customers increase their agility and efficiency, as well as develop new business models that lay the foundation for commercial success down the road. The technology group is headquartered in Frankfurt/Main, has been listed on the stock exchange since 1998 and employs around 1,800 people at 30 locations. The euromicron Group comprises a total of 14 subsidiaries, including the brand names Elabo, LWL-Sachsenkabel, MICROSENS and telent. euromicron AG generated total sales of EUR345 million in fiscal year 2015. euromicron AG Investor & Public Relations Zum Laurenburger Hof 76 60594 Frankfurt am Main Phone: +49 -69-631583-0 Fax: +49-69-631583-17 e-mail: IR-PR@euromicron.de ISIN DE000A1K0300 WKN A1K030 http://www.euromicron.com 03.08.2016 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de --------------------------------------------------------------------------- Language: English Company: euromicron Aktiengesellschaft communication & control technology Zum Laurenburger Hof 76 60594 Frankfurt/Main Germany Phone: +49 69 631583-0 Fax: +49 69 631583-17 E-mail: info@euromicron.de Internet: www.euromicron.de ISIN: DE000A1K0300 WKN: A1K030 Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange End of Announcement DGAP News-Service ---------------------------------------------------------------------------

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sinclair Faces Labor Lawsuit for Break-time Violations

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

TORRAS Cases Balance Protection with Slim Design for 2026

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Survivors Secure $800M Settlement with NY Archdiocese

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Hims & Hers Faces FTC Heat: Investor Class Action Looms

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Love Business Group Helps SMEs Navigate Broadband Choices

Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...